Form 4/A for MLAB MESA LABORATORIES INC /CO/
Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-07 · accession 0001228924-22-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2022-06-13 | 2022-06-07+ | MLAB | Sullivan John James | Dir | M - OptEx | $70.56 | +6,193 | 24.9K | +33% | +$437.0K |
| DA | 2022-06-13 | 2022-06-07 | MLAB | Sullivan John James | Dir | S - Sale+OE | $207.76 | -5,192 | 23.9K | -18% | -$1.08M |
| DMA | 2022-06-13 | 2022-06-07+ | MLAB | Sullivan John James | Dir | X - OptEx | $0.00 | -6,193 | 20.0K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | M | A | 5,192 | $70.56 | 29,049 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-07 | S | D | 5,192 | $207.76 | 23,857 | D | — | — | (F1) Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on February 25, 2021 |
| 3 | Common | Common Stock | 2022-06-09 | M | A | 1,001 | $70.56 | 24,858 | D | — | — | |
| 4 | Derivative | Non Qualified Stock Option | 2022-06-09 | X | D | 800 | $0.00 | 19,026 | D | $70.56 · 2016-04-01 to 2023-04-01 | 800 Common Stock | (F3) 1/7 exercisable on each anniversary date of the 04/01/2015 grant date |
| 5 | Derivative | Incentive Stock Option | 2022-06-09 | X | D | 201 | $0.00 | 19,826 | D | $70.56 · 2016-04-01 to 2023-04-01 | 201 Common Stock | (F3) 1/7 exercisable on each anniversary date of the 04/01/2015 grant date |
| 6 | Derivative | Non Qualified Stock Options | 2022-06-07 | X | D | 5,192 | $0.00 | 20,027 | D | $70.56 · 2016-04-01 to 2023-04-01 | 5,192 Common Stock | (F3) 1/7 exercisable on each anniversary date of the 04/01/2015 grant date |